Test Overview
Clinical Utility
The presence of Hepatitis B Core Antibodies indicates previous or ongoing infection in an undefined time frame. Reflex: Hepatitis B Core IgM Antibodies will be performed (and billed) for reactive specimens.
Method
Chemiluminescent Microparticle Immunoassay
Analytical Platform
Abbott Architect
Method Description
Includes IgG and IgM.
Result Included
Hepatitis B Core Antibodies IgG; Hepatitis B Core Antibodies IgM
Specimen
Specimen Type
SerumVolume
Sample Volume
1 mL
Specimen Comment
Plasma (Heparin) is acceptable only for dialysis patients.
Collection & Handling
Handling Information
Store and send cold.
Performance & Interpretation
Turnaround Time
2 days
Results
Name
Units
Reference Range
Conversion
-
Hepatitis B Core Antibodies TotalQualitative TestNon-Reactive
Referral Location
Canada
Test Version
Last Updated
2024-04-30